Vaccines to prevent pneumonia in children - a developing country perspective.

Show simple item record

dc.contributor.author Oliwa JN, Marais BJ.
dc.date.accessioned 2024-09-03T08:43:15Z
dc.date.available 2024-09-03T08:43:15Z
dc.date.issued 2017-03
dc.identifier.uri https://doi.org/10.1016/j.prrv.2015.08.004
dc.identifier.uri http://repository.kemri.go.ke:8080/xmlui/handle/123456789/1055
dc.description.abstract Pneumonia accounted for 15% of the 6.3 million deaths among children younger than five years in 2013, a total of approximately 935,000 deaths worldwide. Routine vaccination against common childhood illnesses has been identified as one of the most cost-effective strategies to prevent death from pneumonia. Vaccine-preventable or potentially preventable diseases commonly linked with respiratory tract infections include Streptococcus pneumoniae, Haemophilus influenza type-b (Hib), pertussis, influenza, measles, and tuberculosis. Although here have been great strides in the development and administration of effective vaccines, the countries that carry the largest disease burdens still struggle to vaccinate their children and newer conjugated vaccines remain out of reach for many. The Global Vaccine Action Plan (GVAP) has identified priority areas for innovation in research in all aspects of immunisation development and delivery to ensure equitable access to vaccines for all. en_US
dc.language.iso en en_US
dc.publisher Paediatric respiratory reviews. en_US
dc.subject Children; Developing countries; Pneumonia; Vaccines. en_US
dc.title Vaccines to prevent pneumonia in children - a developing country perspective. en_US
dc.type Article en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account